RE:RE:What happened?Skier59, one more issue of how they plan on paying for the 100 patient clinical trial and then the sp should settle into what the market deems is fair until more substantial news is announced. I don't think the day traders will wait for the official start of the trial since I believe most of that is already baked in the sp. I can't see them holding through the patient selection process as that could take months. There's always the possibility of a JV but even then TLT would need money to hold up their end of the bargain. It's unlikely another company would solely bankroll an expensive phase 2 trial without having more evidence of efficacy. If TLT were to report good patient results from different testing sites early on in the trial then that might be a different story. Then again it may take at least the 9 month point of the phase 2 trial to convince both the media and the investing public to take the treatment seriously.